乳腺癌

Epidemiology of Breast CancerEpidemiology and prognosis of breast cancer in young womenLack of patient-reported outcomes assessment in phase III breast cancer studies： a missed opportunity for informed decision makingAdvances in Basic Research of Breast CancerBreast cancer in the young： role of the geneticistAn update on the genomic landscape of breast cancer： new opportunity for personalized therapy?
Towards the elucidation of the mechanisms underlying breast cancer mutationsMembers of the BRCA1 complexes as new susceptibility genes for breast cancerAPOBEC3B spreads somatic mutations in breast cancer genomeFrom genomic data analysis to drug development： a new generation of trials using molecular marker assessment in breast cancerMET deregulation in breast cancerCirculating free DNA in the management of breast cancerImaging Examination of Breast CancerBreast imaging in the young： the role of magnetic resonance imaging in breast cancer screening，diagnosis and follow-upTreatment of Breast CancerChallenges in managing breast cancer during pregnancyPremature menopause in young breast cancer： effects on quality of life and treatment interventionsSurgical TreatmentConservative mastectomies for breast cancer and risk-reducing surgery： the Memorial Sloan Kettering Cancer Center experienceOncoplastic techniques in breast surgery for special therapeutic problemsOncological safety of prophylactic breast surgery： skin-sparing and nipple-sparing versus total mastectomyAnatomy relevant to conservative mastectomyBreast reconstruction following conservative mastectomies： predictors of complications and outcomesSurgical management of breast cancer in China： the Fudan University Shanghai Cancer Center experienceEndocrine TherapyParadigm of polyendocrine therapy in endocrine responsive breast cancer： the role of fulvestrantBisphosphonates in the adjuvant treatment of young women with breast cancer： the estrogen rich is a poor candidate！
Hormonal therapies in young breast cancer patients： when， what and for how long?
A balancing act for breast cancer? Everolimus for hormone receptor positive patientsChemotherapyTreatment of breast cancer in young women： do we need more aggressive therapies?
Neoadjuvant bevacizumab and chemotherapy in breast cancerRadiotherapyImpact of preoperative magnetic resonance imaging in breast cancer patients candidates for an intraoperative partial breast irradiationFirst year experience with IORT for breast cancer at the Geneva University HospitalsCyberKnife stereotaetie body radiotherapy and CyberKnife aeeelerated partial breast irradiation for the treatment of early breast cancerBrest experience in intraoperative radiotherapy for breast cancerIntraoperative radiotherapy with electrons （ELIOT） for early breast cancer： the European Institute of Oneology experienceComparison of the proliferative and elonogenie growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapyThe use of postoperative radiation after nipple sparing mastectomyOptimal management of sentinel lymph node positive biopsy patients in early breast cancerTargeted TherapyShould trastuzumab be administered concomitantly with anthracycline in women with early， HER2-positive breast cancer?
Pertuzumab in metastatic breast cancer： unanswered questionsPertuzumab： a step forward in treating HER2-positive breast cancerBevacizumab： Where do we go from here in breast cancer?
Lapatinib as a therapeutic option in brain metastases from HER2+ breast cancerThe ALTERNATE trial： assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancerNanoparticle TherapyTheranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancerPrognosis of Breast CancerFertility counseling of young breast cancer patientsSexuality and breast cancer： prime time for young patientsBreast cancer and sleep disturbance： more than simply a quality of life concernBrain metastases in HER2 positive breast cancer： the next hurdleBrain metastases in HER2-positive breast cancer： challenges and opportunities